| Literature DB >> 36232869 |
Hayato Terayama1, Kou Sakabe1,2, Daisuke Kiyoshima1, Ning Qu1, Tsutomu Sato1, Kaori Suyama1, Shogo Hayashi1, Kenichi Sakurai3, Emiko Todaka3,4, Chisato Mori3,4.
Abstract
Neonicotinoid pesticides (NPs) are neurotoxic substances. They are highly effective as insecticides owing to their water solubility, permeability, and long-lasting activity. These molecules are structurally similar to nicotine and act as nicotinic acetylcholine receptor agonists. The administration of NPs to experimental animals reportedly causes neuromuscular and reproductive disorders. Moreover, recently reported problems caused by NPs include damage to land-dwelling creatures (such as mammals and birds), hydrobiology, and ecosystems. This review summarizes the recent reports on NP concentrations detected in river systems in several Japanese regions. These values were lower than the environmental standard values; however, seasonal variations were observed. Furthermore, reports on NP-induced testicular and ovarian toxicity were examined, revealing that the mechanism of injury is mainly driven by oxidative stress. The use of NPs is declining worldwide, except in Japan; therefore, continuous monitoring remains necessary.Entities:
Keywords: ecosystem; neonicotinoid pesticide; ovary; river water; testis; toxicity
Mesh:
Substances:
Year: 2022 PMID: 36232869 PMCID: PMC9570366 DOI: 10.3390/ijms231911567
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Circulation of pesticides in the ecosystem.
Maximum concentrations and sampling months of neonicotinoid pesticides in Japanese rivers, as reported in previous studies.
| Region | Sampling Point | Time of | Compound | Maximum | Sampling Month with Maximum Concentration | Reference |
|---|---|---|---|---|---|---|
| Kanagawa | Upstream–downstream of the Tsurumi River | May–December 2009 | Imidacloprid | 0.42 | July | [ |
| Acetamiprid | 0.06 | June | ||||
| Midstream–downstream of the Sagami River | Late April 2014–Mid-March 2015 | Imidacloprid | 0.104 | June | [ | |
| Acetamiprid | 0.023 | - 1 | ||||
| Thiacloprid | 0.002 | - | ||||
| Thiamethoxam | 0.202 | - | ||||
| Dinotefuran | 0.048 | - | ||||
| Clothianidin | 0.085 | June | ||||
| Upstream–downstream of the Kaname River | April–December 2017 | Imidacloprid | 0.836 | June | [ | |
| Acetamiprid | 0.779 | July | ||||
| Thiacloprid | 0.006 | November | ||||
| Thiamethoxam | 0.029 | November | ||||
| Nitenpyram | N.D. 2 | - | ||||
| Dinotefuran | 0.373 | August | ||||
| Clothianidin | 0.482 | May | ||||
| Midstream–downstream of the Kaname River * | April–August, November 2018, March 2019 | Imidacloprid | 0.095 | June | [ | |
| Acetamiprid | 0.004 | June | ||||
| Thiacloprid | Unclear | - | ||||
| Thiamethoxam | 0.011 | May | ||||
| Nitenpyram | Unclear | - | ||||
| Dinotefuran | 0.043 | August | ||||
| Clothianidin | 0.053 | June | ||||
| Fipronil | 0.037 | June | ||||
| Fukui | Downstream of the Kuzuryu River | April–November 2018 | Imidacloprid | 0.055 | May | [ |
| Acetamiprid | 0.0012 | August | ||||
| Thiacloprid | 0.0012 | - | ||||
| Thiamethoxam | 0.076 | May | ||||
| Nitenpyram | N.D. | - | ||||
| Dinotefuran | 0.27 | August | ||||
| Clothianidin | 0.13 | August | ||||
| Fipronil | 0.0045 | - | ||||
| Tokyo | Midstream of the Tama River | April–May 2017 | Imidacloprid | 0.0084 | - | [ |
| Acetamiprid | 0.00094 | - | ||||
| Thiacloprid | 0.00045 | - | ||||
| Thiamethoxam | 0.0037 | - | ||||
| Nitenpyram | N.D. | - | ||||
| Dinotefuran | 0.0089 | - | ||||
| Clothianidin | 0.047 | - | ||||
| Fipronil | 0.0018 | - |
Papers cited in Table 1 were selected from the Google Scholar website (https://scholar.google.co.jp/, accessed on 28 July 2022). * These values were read from the line graph published in the article. 1 -: no data were published in the cited study. 2 N.D.: pesticide was not detected. Table 1 is a revised version of a table from a previous study [39].
Environmental standards and food standards for various neonicotinoid pesticides in Japan (as of 29 June 2021).
| Standard Type | Standard Name | Imidacloprid | Acetamiprid | Thiacloprid | Thiamethoxam | Nitenpyram | Dinotefuran | Clothianidin | Fipronil | Reference |
|---|---|---|---|---|---|---|---|---|---|---|
| Environmental standard (μg/L) | Registration withholding standards for agricultural chemicals with reference to prevention of toxicity to aquatic plants and animals | 1.9 | 2.5 | 3.6 | 3.5 | 11 | 12 | 2.8 | 0.024 | [ |
| Registration withholding standards for agricultural chemicals with reference to prevention of water pollution | 150 | 180 | 31 | 47 | 1400 | 580 | 250 | 0.5 | ||
| Food standard (μg/kg) | Acceptable daily intake (ADI) | 57 | 71 | 12 | 18 | 530 | 220 | 97 | 0.19 | |
| Acute reference dose (ARfD) | 100 | 100 | 31 | 500 | 600 | 1200 | 600 | 20 |
Table 2 is a revised version of a table from a previous study [39].
Various effects of neonicotinoid pesticides determined in previous reports on testes.
| Subject | Target | Age at Initial | Dose (Per Day) | Exposure Period | Administration Method | Conclusion | Reference | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Testis Weight | Spermatogenesis | Androgen | Oxidative Stress | Cell Death | Other | |||||||
| Imidacloprid | Wistar albino rat | 8–9 weeks | 0.5, 2, 8 mg/kg | 90 days | Oral | N.S. 1 | •Decreased epididymal sperm concentration (2, 8 mg/kg) and sperm motility (8 mg/kg) | •Decreased serum testosterone (8 mg/kg) | •Decreased GSH in the testis (8 mg/kg) | - | •Decreased relative weights of epididymis, right cauda epididymis, and seminal vesicles (8 mg/kg) | [ |
| Wistar albino rat | 7 days | 0.5, 2, 8 mg/kg | 90 days | Oral | N.S. | •Decreased epididymal sperm concentration (8 mg/kg) | •Decreased serum testosterone (0.5, 2, 8 mg/kg) | •Increased MDA and decreased GSH in the testis (8 mg/kg) | - | •Increased testicular levels of palmitic, palmitoleic, stearic, oleic, linoleic, dihomo-γ-linolenic, arachidonic, docosapentaenoic acids as well as total lipid values (0.5, 2, 8 mg/kg). | [ | |
| Wistar albino rat | 8 weeks | 45, 90 mg/kg | 28 days | Oral (gavage) | N.S. | •Decreased total epididymal sperm count, sperm motility, and live sperm count (45, 90 mg/kg) | •Decreased testicular 3β-HSD, 17β-HSD, and testosterone and serum testosterone (45, 90 mg/kg) | •Decreased protein concentration, reduced GSH, SOD, and GPx activity (45, 90 mg/kg) and CAT and GST activity in the testis (90 mg/kg) | - | •Decreased weight of epididymis (45, 90 mg/kg) | [ | |
| Sprague–Dawley rat | 4 weeks and 7 weeks | 1 mg/kg | 65 days | Oral (- 3) | Decreased(4 and 7 weeks) | •Decreased epididymal sperm concentration, motility, intact seminal DNA percentage, and viable sperm percentage (4 and 7 weeks). | •Decreased serum testosterone, serum LH, serum estradiol, 3β-HSD mRNA, and NR5A1 mRNA (4 and 7 weeks). | •Increased 8-OHdG and OGG1 mRNA (4 and 7 weeks) | •Intense BAX-positive immunolabeling of the spermatogonial cell cytoplasm with moderate signals in the remaining spermatozoa (7 weeks)•Intense BAX-positive immunolabeling of the spermatogonial cell cytoplasm (3 weeks) | - | [ | |
| Wistar rat | 12–14 weeks | 16.9 mg/kg | 28 days | Oral (-) | N.D. 2 | - | - | •Decreased GST, GR, GPx, CAT, and SOD activity and mean TTH in the testis | - | - | [ | |
| ICR mouse | 6 weeks | 3, 10, 30 mg/L | 70 days | Oral (-) | Decreased(30 mg/L) | • Decreased seminiferous tubule score determined by the Johnson scoring method in the testis (30 mg/L) | •Decreased serum testosterone, estradiol, and aromatase; testicular TC (30 mg/L) and serum LDL-C (10, 30 mg/L)•Decreased SR-B1 (3 mg/L), StAR, PBR, AR (10, 30 mg/L), P450scc, 3β-HSD (3, 10, 30 mg/L), P45017a, 17β-HSD, and HMG-CoA (30 mg/L) mRNA | - | - | •Imidacloprid showed binding affinity to the androgen receptor | [ | |
| Thiacloprid | Wistar albino rat | Adult | 22.5 mg/kg | 30 days | Oral | N.S. | •Decreased epididymal sperm concentration, sperm motility, sperm viability, and testicular DNA contents | - | •Decreased SOD, CAT, and GPx activity and SOD, CAT, and GPx mRNA in the testis•Increased GSH, MDA, and AOPP in the testis | •Smear (a hallmark of necrosis) without ladder formation on agarose gel by the DNA fragmentation method in the testis | - | [ |
| Clothianidin | Wistar albino rat | 7 days | 2, 8, 32 mg/kg | 90 days | Oral | N.S. | •Decreased epididymal sperm concentration (32 mg/kg) | •Decreased serum testosterone protein (32 mg/kg) | •Decreased GSH (32 mg/kg) | •Increased apoptotic index in the germinal epithelium of the testis and fragmentation of the seminal DNA (32 mg/kg) | •Increased palmitic acid (8 mg/kg), arachidonic acid, docosapentaenoic acid (8, 32 mg/kg), testicular tissue cholesterol level (32 mg/kg), palmitoleic acid, and total lipid values (2, 8, 32 mg/kg) in the testis | [ |
| Wistar albino rat | 8–9 weeks | 2, 8, 24 mg/kg | 90 days | Oral | N.S. | N.S. | N.S. | - | - | •Decreased relative weights of epididymis (2, 8, 24 mg/kg), right cauda epididymis (8 mg/kg), and seminal vesicles (2, 8 mg/kg) | [ | |
| C57BL/6NCrSlc Mouse | 8 weeks | 10, 50, 250 mg/kg | 28 days | Oral | N.S. | •Abnormal GPx4 immunoreactivity in Sertoli cells of the seminiferous tubules that also showed marked degeneration (250 mg/kg) | - | - | - | - | [ | |
| C57BL/6NCrSlc Mouse(Male offspring postnatally on day 14) | Gestational day 1 | 10, 50 mg/kg | Approximately 30 days | Oral | N.S. | •Decreased number of germ cells per seminiferous tubule (50 mg/kg) | N.S. | - | - | - | [ | |
| Acetamiprid | Sprague–Dawley rat | 5 weeks | 10, 30 mg/kg | 35 days | Oral | Decreased(10, 30 mg/kg) | •Decreased number of spermatids and epididymal sperm (10, 30 mg/kg) | •Decreased plasma testosterone (30 mg/kg), Leydig cell number, StAR mRNA, Cyp11a1 mRNA, and 3β-HSD mRNA (10, 30 mg/kg) in the testis, cAMP (30 mg/kg), and ATP in the Leydig cells (10, 30 mg/kg)•Increased plasma LH (30 mg/kg), MDA, and NO in the Leydig cells (10, 30 mg/kg) | - | - | - | [ |
| A/J mouse | 3 weeks | Average 2.6 and 21.4 mg/mouse | 180 days | Oral | N.S. | •Decreased Ki-67 (21.4 mg) and Top2a (2.6 and 21.4 mg) mRNA | •Decreased LH receptor, StAR, Cyp11a1, HSD17b3 (21.4 mg), and Cyp17a1mRNA (2.6 and 21.4 mg) in the testis | - | - | •Acetamiprid concentrations detected: 63.9 pg/mL in the serum and 7.1 pg/mL in the testis (21.4 mg) | [ | |
| Sprague–Dawley rat | 8–10 weeks | 12.5, 25, 35 mg/kg | 90 days | Oral | N.S. | •Decreased epididymal sperm concentration (25, 35 mg/kg) and seminiferous tubule score determined by the modified Johnson scoring method and proliferation index determined by the PCNA method in the testicular tissue (12.5, 25, 35 mg/kg). | •Decreased cholesterol (25, 35 mg/kg) in the plasma | •Decreased GSH and TAS in the plasma and GSH and TAS in the testis (12.5, 25, 35 mg/kg) | • Increased apoptotic index determined by the TUNEL method in the testicular tissue (12.5, 25, 35 mg/kg) | - | [ | |
Table 3 is a revised version of a table presented in a previous study [57]. Papers cited in Table 3 were selected from the PUBMED website (https://pubmed.ncbi.nlm.nih.gov, accessed on 28 July 2022). 1 N.S.: difference not significant. 2 N.D.: testis weight not detected. 3 -: no data were published in the cited study. AOPP, advanced oxidation protein product; ATP, adenosine triphosphate; AR, androgen receptor; BAX, BCL2-associated X protein; cAMP, cyclic adenosine monophosphate; CAT, catalase; Cyp11a1, cytochrome P450 family 11 subfamily A member 1; Cyp17a1, cytochrome P450 family 17 subfamily A; FSH, follicle-stimulating hormone; GPx, glutathione peroxidase; GPx4, glutathione peroxidase 4; GR, glutathione reductase; GSH, glutathione; GST, glutathione S-transferase; HMG-CoA, 3-hydroxy-3-methyl-glutaryl CoA synthase; HSD17b3, 17β-hydroxysteroid dehydrogenase 3; LDH-x, lactate dehydrogenase-x; LDL-C, low-density lipoprotein cholesterol; LH, luteinizing hormone; LPO, lipid peroxidation; MDA, malondialdehyde; NO, nitric oxide; NR5A1, nuclear receptor family 5 group A member 1; nAChRα4, nicotinic acetylcholine receptor α4; nAChRα7, nicotinic acetylcholine receptor α7; OGG1, 8-oxoguanine glycosylase; PBR, peripheral benzodiazepine receptor; PCNA, proliferating cell nuclear antigen; P450scc, cytochrome P450 cholesterol side-chain cleavage enzyme; P45017a, cytochrome P450 family 17 subfamily A; ROS, reactive oxygen species; SDH, sorbitol dehydrogenase; SOD, superoxide dismutase; SR-B1, scavenger receptor class B member 1; StAR, steroidogenic acute regulatory protein; TAS, total antioxidant status; TC, total cholesterol; Top2a, DNA topoisomerase II alpha; TOS, total oxidant status; TTH, total thiol level; γ-GT, γ-glutamyltranspeptidase; 3β-HSD, 3β-hydroxysteroid dehydrogenase; 8-OHdG, 8-hydroxy-2′-deoxyguanosine; 17β-HSD, 17β-hydroxysteroid dehydrogenase.
Effects of neonicotinoid pesticides on the ovary reported in previous studies.
| Subject | Target | Age at Initial | Dose (Per Day) | Exposure | Administration Method | Conclusion | Reference | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ovary Weight | Oogenesis | Female Hormones | Oxidative Stress | Cell Death | Other | |||||||
| Imidacloprid | 7 days | 5, 10, 20 mg/kg | 90 days | oral | Decreased (20 mg/kg) | - 1 | •Increased serum FSH (20 mg/kg) | •Increased LPO in the ovary (20 mg/kg) | - | - | [ | |
| Rat | 10–12 weeks | 50, 200, 300 mg/kg | 60 days | oral | Decreased (50, 200, 300 mg/kg) | •Increased relative volume of atretic follicles against total follicles (50, 200, 300 mg/kg) | •Decreased serum 17β-estradiol (50, 200, 300 mg/kg) | •Increased ovarian AOPP and MDA (50, 200, 300 mg/kg) | - | - | [ | |
| Clothianidin | C57BL/6NCrSlc Mouse | Gestational period | 65 mg/kg | The dams (pregnant mouse) were given soft gel with or without CLO from gestational day 1.5 to postnatal day 21 period. | oral | Decreased (3 weeks) | N.S. 2 | •Decreased 17-hydroxyprogesterone (17-OH progesterone) and corticosterone in the blood (10 weeks) | •Decreased GPx4 immunoreactivity in the ovary (3 weeks and 10 weeks) | - | - | [ |
Papers cited in Table 4 were selected from the PUBMED website (https://pubmed.ncbi.nlm.nih.gov, accessed on 28 July 2022). 1 -: no data were published in the cited study. 2 N.S.: no significant difference. AOPP, advanced oxidation protein product; CAT, catalase; FSH, follicle-stimulating hormone; GPx, glutathione peroxidase; GPx4, glutathione peroxidase 4; GSH, glutathione; LH, luteinizing hormone; LPO, lipid peroxidation; MDA, malondialdehyde; SOD, superoxide dismutase.